Evidence map›Paper›PMID 37789009›Full record

ArticleSignal transduction and targeted therapy2023

Gut microbe-derived metabolite indole-3-carboxaldehyde alleviates atherosclerosis.

Yijing Lu, Wenlong Yang, Zhiyong Qi, Rifeng Gao, Jing Tong, Tingwen Gao, Yin Zhang, Aijun Sun, Shuning Zhang, Junbo Ge

Abstract readLetter
In one paragraph

Article in Signal transduction and targeted therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Review
  2. Indole-3-carboxaldehyde fromGut microbes · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Glycyrrhizic Acid Alleviates Atherosclerosis inInternational journal of molecular sciences · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yijing Lu *Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Wenlong Yang *Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhiyong QiDepartment of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Rifeng GaoDepartment of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Jing TongDepartment of Cardiology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
Tingwen GaoDepartment of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Yin ZhangDepartment of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Aijun SunDepartment of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China. sun.aijun@zs-hospital.sh.cn.
Shuning ZhangDepartment of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China. zhang.shuning@zs-hospital.sh.cn.
Junbo GeDepartment of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China. jbge@zs-hospital.sh.cn.ORCID http://orcid.org/0000-0002-9360-7332

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AtherosclerosisGastrointestinal MicrobiomeHumansIndolesindole-3-carbaldehydeIndoles

Identifiers

PMID37789009
PMCPMC10547776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.